Evidence map›Paper›PMID 29893459›Full record

ReviewAngewandte Chemie (International ed. in English)2019

Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.

Aleksandar Bijelic, Manuel Aureliano, Annette Rompel

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Peroxo-Containing Heteropolyanions [{XWInorganic chemistry · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Active Learning-Assisted Exploration of [POAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Data-Driven Polyoxometalate Chemistry.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Self-Assembly Engineering of Fullerene-Like Polyhedra: VAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  16. Article
  17. Article
  18. Donut-shaped [NaPJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Article
  19. Exploring New Bioorthogonal Catalysts: Scaffold Diversity in Catalysis for Chemical Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aleksandar BijelicUniversität Wien, Fakultät für Chemie, Institut für Biophysikalische Chemie, Althanstraße 14, 1090, Wien, Austria.ORCID 0000-0002-8781-153X
Manuel AurelianoUniversidade do Algarve, Faculdade de Ciências e Tecnologia (FCT), CCMar, 8005-139, Faro, Portugal.ORCID 0000-0003-4858-3201
Annette RompelUniversität Wien, Fakultät für Chemie, Institut für Biophysikalische Chemie, Althanstraße 14, 1090, Wien, Austria.ORCID 0000-0002-5919-0553

Funding

Austrian Science Fund P27534Austrian Science Fund FWF P 27534FCT, Foundation for Science and Technology SFRH/BSAB/129821/2017FCT, Foundation for Science and Technology UID/Multi/04326/2013
6 · The paper itself

Abstract

Polyoxometalates (POMs) are an emerging class of inorganic metal oxides, which over the last decades demonstrated promising biological activities by the virtue of their great diversity in structures and properties. They possess high potential for the inhibition of various tumor types; however, their unspecific interactions with biomolecules and toxicity impede their clinical usage. The current focus of the field of biologically active POMs lies on organically functionalized and POM-based nanocomposite structures as these hybrids show enhanced anticancer activity and significantly reduced toxicity towards normal cells in comparison to unmodified POMs. Although the antitumor activity of POMs is well documented, their mechanisms of action are still not well understood. In this Review, an overview is given of the cytotoxic effects of POMs with a special focus on POM-based hybrid and nanocomposite structures. Furthermore, we aim to provide proposed mode of actions and to identify molecular targets. POMs are expected to develop into the next generation of anticancer drugs that selectively target cancer cells while sparing healthy cells.

Indexed as

AnimalsAntineoplastic AgentsDrug DiscoveryHumansModels, MolecularMolybdenumNeoplasmsNiobiumOrganometallic CompoundsPolyoxometalatesTungstenTungsten CompoundsVanadiumAntineoplastic AgentsMolybdenumNiobiumOrganometallic Compoundspolyoxometalate IPolyoxometalatesTungstenTungsten CompoundsVanadiumantitumor agentsbiological activitycancernanoparticlespolyoxometalates

Identifiers

PMID29893459
PMCPMC6391951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.